Activating Behavior for Lasting Engagement After Stroke
Status: | Completed |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/27/2019 |
Start Date: | September 29, 2017 |
End Date: | January 4, 2019 |
Stroke survivors demonstrate high levels of sedentary behavior, placing them at risk for
exacerbation of chronic health conditions. This may lead to recurrent stroke. Subtle
cognitive impairments are common after stroke and can lead to difficulty self-monitoring and
problem solving to overcome barriers to physical activity. Investigators developed the
Activating Behavior for Lasting Engagement (ABLE) intervention to promote activity
scheduling, self-monitoring, and problem solving activity over the full day. This study
examines the effects of the ABLE intervention on sedentary behavior after stroke.
exacerbation of chronic health conditions. This may lead to recurrent stroke. Subtle
cognitive impairments are common after stroke and can lead to difficulty self-monitoring and
problem solving to overcome barriers to physical activity. Investigators developed the
Activating Behavior for Lasting Engagement (ABLE) intervention to promote activity
scheduling, self-monitoring, and problem solving activity over the full day. This study
examines the effects of the ABLE intervention on sedentary behavior after stroke.
Inclusion Criteria:
1. diagnosis of ischemic or hemorrhagic stroke
2. ≥6 months and ≤24 months post-stroke
3. ≥18 years of age
4. ambulatory in the community with or without an assistive device (e.g. walker, cane)
5. self-reported sedentary behavior (≥6 hours/day of sedentary behavior reported using
the Sedentary Behavior Questionnaire)
6. reside within 50 miles of Pittsburgh, Pennsylvania
Exclusion Criteria:
1. severe aphasia (Boston Diagnostic Aphasia Examination score ≤1)
2. currently receiving outpatient or home care rehabilitation services (physical therapy,
occupational therapy, or speech therapy)
3. current active cancer treatment
4. medical history of neurodegenerative disorder (i.e. dementia, Parkinson's disease,
multiple sclerosis, Lou Gehrig's disease (ALS), glioblastoma, myasthenia gravis)
5. current major depressive disorder, psychiatric condition, substance abuse (Patient
Health Questionnaire-9, PRIME-MD/MINI)
We found this trial at
1
site
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
Pittsburgh, Pennsylvania 15260
(412) 624-4141
Phone: 412-383-4085
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
Click here to add this to my saved trials